EK
Elianna (Elizabeth) Knight
Investor·Two Sigma Ventures
Elianna Knight is listed by Two Sigma Ventures as an investor and an M.D. candidate at Yale School of Medicine. Her research includes medical applications of quantum machine learning, latent diffusion models for antibody CDR generation, and prior work on polygenic risk scores and biomarker variation at Stanford. Before TSV, she worked as a data scientist at an Ethereum infrastructure company and as a programmer at a genetics company.
See the rest of Elianna (Elizabeth) Knight's profile.
Deal history, investment focus, outreach angles and the rest of the background. One email, no password — we send a link and you land right back here.